ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably
Source: SeekingAlpha
2026-01-31 04:40:57 ET
...
Read the full article on Seeking Alpha
For further details see:
ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably
ProKidney Corp.
NASDAQ: PROK
PROK Trading
-2.55% G/L:
$2.295 Last:
229,166 Volume:
$2.35 Open:
PROK Latest News
January 06, 2026 07:30:00 am
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
PROK Stock Data
$604,677,102
98,372,842
N/A
82
N/A
Biotechnology & Life Sciences
Healthcare
US
Winston-Salem
